Ultra纳斯达克生物科(BIB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BIB Ultra纳斯达克生物科

休市中 07-24 16:00:00 EDT

97.88

-1.15

-1.16%

盘后98.19

+0.31+0.31%

19:34 EDT

最高100.00	最低97.68	成交量3,484
今开100.00	昨收99.04	日振幅2.34%
总市值8,222万	流通市值8,222万	总股本84.00万
成交额34.33万	换手率0.41%	流通股本84.00万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BIB","market":"US","secType":"STK","nameCN":"Ultra纳斯达克生物科","latestPrice":97.8824,"timestamp":1784923200000,"preClose":99.0358,"halted":0,"volume":3484,"hourTrading":{"tag":"盘后","latestPrice":98.19,"preClose":97.8824,"latestTime":"19:34 EDT","volume":12,"amount":1175.992,"timestamp":1784936048635,"change":0.3076,"changeRate":0.003143,"amplitude":0},"delay":0,"changeRate":-0.01164629356252982,"floatShares":840000,"shares":840000,"eps":0,"marketStatus":"休市中","change":-1.1534,"latestTime":"07-24 16:00:00 EDT","open":100,"high":100,"low":97.6801,"amount":343272.05718,"amplitude":0.023425,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1785139200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":99.0358,"sharesOutstanding":1040000,"nav":98.9951,"aum":83155884,"dividendRate":0.003339,"bidAskSpread":0.003372,"postHourTrading":{"tag":"盘后","latestPrice":98.19,"preClose":97.8824,"latestTime":"19:34 EDT","volume":12,"amount":1175.992,"timestamp":1784936048635,"change":0.3076,"changeRate":0.003143,"amplitude":0},"volumeRatio":0.4105779149189721,"impliedVol":0.4187,"impliedVolPercentile":0.2988},"requestUrl":"/m/hq/s/BIB","defaultTab":"news","newsList":[{"id":"2653895100","title":"吉利德科学(GILD)肿瘤组合疗法获欧洲药品管理局旗下CHMP推荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2653895100","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653895100?lang=zh_cn&edition=full","pubTime":"2026-07-24 18:45","pubTimestamp":1784889935,"startTime":"0","endTime":"0","summary":"金吾财讯 | 吉利德科学 宣布，欧洲药品管理局旗下人用药品委员会已发布积极意见，建议批准其Trop-2靶向ADC药物Trodelvy联合帕博利珠单抗，用于既往未接受过全身治疗、且肿瘤PD-L1表达阳性的不可切除局部晚期或转移性三阴性乳腺癌成人患者。若欧盟委员会于2026年晚些时候正式批准该联合疗法，Trodelvy将实现从单药到联合疗法、全面覆盖不同PD-L1表达状态的mTNBC一线治疗布局。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210810/NmQ4YmNlMWEyMTYyODU5MDQwMjQzMA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NmQ4YmNlMWEyMTYyODU5MDQwMjQzMA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302998","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","SG9999015986.USD","LU1057294990.SGD","LU0234570918.USD","SG9999015952.SGD","LU1571399168.USD","LU1585245621.USD","IE00BSNM7G36.USD","LU1023059063.AUD","LU0965509101.SGD","BMED","SG9999015978.USD","BK4550","IBBQ","LU2089984988.USD","LU0823416689.USD","BBH","LU0965509010.AUD","BK4568","IE00B3T34201.USD","SG9999015945.SGD","LU0965508806.USD","BK4585","CHMP","LU0289739699.SGD","LU0320765992.SGD","LU1066051498.USD","LU1061106388.HKD","GILD","BIB","TBXU","BK4588","IBB","LU2468319806.SGD","IE00BZ1G4Q59.USD","BK4139","BK4578","LU2087621335.USD","TMED","LU1037948541.HKD","LU1934455194.USD","IE00B19Z3581.USD","IE0002270589.USD","MEDI","BK4583","LU1674673428.USD","LU1934455863.HKD","LU2324357040.USD","LU0122379950.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185859812","title":"CHMP推荐吉利德Trodelvy®联合Keytruda®用于PD-(L)1阳性一线转移性三阴性乳腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1185859812","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185859812?lang=zh_cn&edition=full","pubTime":"2026-07-24 18:29","pubTimestamp":1784888958,"startTime":"0","endTime":"0","summary":"欧洲药品管理局人用药品委员会（CHMP）近日给出推荐意见，支持吉利德科学的Trodelvy®与Keytruda®联合使用，用于治疗PD-(L)1阳性的一线转移性三阴性乳腺癌患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","BK4568","LU0234570918.USD","LU2087621335.USD","LU2468319806.SGD","IE0002270589.USD","LU1585245621.USD","MEDI","SG9999015978.USD","LU0965509283.SGD","TBXU","IE00B7SZLL34.SGD","LU1839511570.USD","LU1934455277.USD","LU0965508806.USD","BK4585","TMED","BMED","IE00B3T34201.USD","LU0109394709.USD","LU0114720955.EUR","LU1778281490.HKD","BK4532","LU1037948897.HKD","LU1037948541.HKD","LU2324357040.USD","LU1571399168.USD","LU2089984988.USD","BK4578","GILD","BBH","LU0823416689.USD","LU1934455194.USD","BK4588","IE00B19Z3581.USD","BK4139","BIB","IBB","LU1066053197.SGD","LU1066051498.USD","LU0122379950.USD","LU0289739699.SGD","SG9999015945.SGD","IE00BSNM7G36.USD","IBBQ","BK4583","SG9999015986.USD","LU1057294990.SGD","SG9999015952.SGD","IE00B19Z3B42.SGD","BK4566","BK4550","LU0320765992.SGD","LU1061106388.HKD","LU1674673428.USD","LU0861579265.USD","LU0965509101.SGD","IE00BKVL7J92.USD","LU1430594728.SGD","LU1934455863.HKD","IE00BZ1G4Q59.USD","LU1674673691.USD","LU0058720904.USD","LU1023059063.AUD","LU2112291526.USD","LU0965509010.AUD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653074709","title":"百济神州/安进 FIC 双抗，皮下制剂进入 III 期","url":"https://stock-news.laohu8.com/highlight/detail?id=2653074709","media":"新浪医药","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653074709?lang=zh_cn&edition=full","pubTime":"2026-07-23 19:30","pubTimestamp":1784806200,"startTime":"0","endTime":"0","summary":"7 月 22 日，药物临床试验登记与信息公示平台显示，安进和百济神州共同登记了一项在接受含铂一线化疗后的复发性广泛期小细胞肺癌试验参与者中比较 Tarlatamab皮下给药与静脉给药的 III 期研究DeLLphi-315。在皮下剂型的开发方面，安进和百济神州于 2024 年 9 月启动了一项在广泛期小细胞肺癌受试者中评价 Tarlatamab 皮下给药的安全性、耐受性、药代动力学和初步抗肿瘤活性的 Ib 期研究 DeLLphi-308。而本次启动的DeLLphi-315 研究是塔拉妥单抗皮下给药方案启动的首个 III 期临床试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-07-23/doc-iniivazc5268721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IBB","LU1719994722.HKD","LU2242652126.USD","TBXU","LU1983299246.USD","BK1588","BK4139","LU1061106388.HKD","688235","BK1583","IBBQ","PJP","LU0889565916.HKD","LU2242646821.SGD","AMGN","LU0122379950.USD","LU0320765992.SGD","BK4581","06160","BK4585","LU1969619763.USD","IE0009355771.USD","BK1500","LU1251922891.USD","LU1571399168.USD","SG9999001440.SGD","LU0058720904.USD","LU2112291526.USD","BK4134","LU0588546209.SGD","PBE","LU0289739699.SGD","LU0307460666.USD","LU0868494617.USD","LU1303224171.USD","IE00B4R5TH58.HKD","LU1770034418.SGD","LU2468319806.SGD","BK4534","BK4599","IE00BJT1NW94.SGD","ONC","BIB","BBH","IE0002141913.USD","III","LU2328871848.SGD","KURE","IE00BFTCPJ56.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169878111","title":"Leerink Partners下调吉利德科学评级至“与大盘持平”，目标价大幅调降至127美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1169878111","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169878111?lang=zh_cn&edition=full","pubTime":"2026-07-21 12:03","pubTimestamp":1784606620,"startTime":"0","endTime":"0","summary":"投资银行Leerink Partners调整了对生物技术公司吉利德科学的股票评级。该机构将其评级从原先的“跑赢大盘”下调至“与大盘持平”，反映出其对该公司近期前景更为审慎的看法。\n与此同时，Leerink Partners也显著下调了吉利德科学的目标股价，从每股146美元大幅削减至127美元。这一调整意味着该机构对该公司未来股价的预期有所降低。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","LU0122379950.USD","LU1037948897.HKD","LU1066051498.USD","IBB","BK4588","BK4550","LU1934455863.HKD","SG9999015986.USD","BK4139","LU0965508806.USD","BK4585","LU1571399168.USD","LU2468319806.SGD","LU1057294990.SGD","IE00BSNM7G36.USD","LU2112291526.USD","LU2087621335.USD","LU0882574055.USD","LU2089984988.USD","LU1430594728.SGD","LU0965509101.SGD","BK4532","BBH","LU1585245621.USD","LU1934455277.USD","LU0114720955.EUR","LU2324357040.USD","BIB","MEDI","LU0889565916.HKD","LU1037948541.HKD","SG9999015978.USD","IE00B7SZLL34.SGD","IE00B19Z3581.USD","BK4568","LU0965509010.AUD","TMED","BK4583","BK4578","LU1778281490.HKD","LU1839511570.USD","LU0861579265.USD","SG9999015945.SGD","IE00B3T34201.USD","LU0109394709.USD","LU1674673691.USD","BMED","LU0965509283.SGD","IE00B19Z3B42.SGD","BK4566","IE0002270589.USD","LU1066053197.SGD","IE00BZ1G4Q59.USD","LU0058720904.USD","TBXU","LU1023059063.AUD","IE00BKVL7J92.USD","LU0823416689.USD","LU1061106388.HKD","LU1674673428.USD","LU1934455194.USD","GILD","SG9999015952.SGD","LU0320765992.SGD","IBBQ","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653210240","title":"Leerink下调吉利德科学目标价至127美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2653210240","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653210240?lang=zh_cn&edition=full","pubTime":"2026-07-21 10:35","pubTimestamp":1784601350,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00B7SZLL34.SGD","BK4585","LU0965509283.SGD","LU2324357040.USD","LU0058720904.USD","LU0965509101.SGD","LU0320765992.SGD","LU1037948541.HKD","IE00BKVL7J92.USD","IE00B19Z3B42.SGD","BBH","LU2087621335.USD","LU2468319806.SGD","LU1778281490.HKD","LU2089984988.USD","MEDI","BIB","LU0109394709.USD","LU0861579265.USD","LU0965509010.AUD","LU1674673691.USD","LU0289739699.SGD","LU1674673428.USD","LU1839511570.USD","BK4583","LU1934455863.HKD","BK4550","LU0114720955.EUR","SG9999015978.USD","SG9999015986.USD","LU1585245621.USD","IE00BZ1G4Q59.USD","LU0234570918.USD","LU1023059063.AUD","SG9999015945.SGD","LU0882574055.USD","UDN","LU1066053197.SGD","GILD","BMED","LU0823416689.USD","BK4139","IBB","BK4578","LU2112291526.USD","LU0889565916.HKD","IBBQ","LU0122379950.USD","UUP","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651117599","title":"Vertex(VRTX)百亿美元收购罕见病药企 拓宽内分泌管线布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2651117599","media":"金吾财讯","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651117599?lang=zh_cn&edition=full","pubTime":"2026-07-13 22:10","pubTimestamp":1783951848,"startTime":"0","endTime":"0","summary":"金吾财讯 | Vertex Pharmaceuticals  与 Crinetics Pharmaceuticals  共同披露收购协议，企业将以每股 85 美元现金完成标的全额收购，交易对应 Crinetics 整体股权价值约 100 亿美元，扣除标的账面现金后净交易对价 88 亿美元，交易预计 2026 年第三季度完成，消息落地后 Crinetics 盘后股价实现翻倍上涨。Vertex 计划依托自有现金搭配债务工具完成交易资金筹措，美国银行、摩根士丹利提供 45 亿美元全额过渡性融资，收购落地后企业罕见病内分泌赛道产品矩阵将实现大幅扩容。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210625/NjJmZjg2MTAxNTM3NTgyMzkx.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/NjJmZjg2MTAxNTM3NTgyMzkx.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302497","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0256863811.USD","BK4588","LU1035775433.USD","LU0079474960.USD","LU2362541273.HKD","LU0757428866.USD","IBB","IE00B19Z3581.USD","LU1093756325.SGD","BIB","LU1778281490.HKD","IE0009355771.USD","LU1069344957.HKD","IE00B4R5TH58.HKD","LU1674673428.USD","LU2362540622.SGD","IDNA","SG9999001176.USD","SG9999013999.USD","LU1585245621.USD","VERX","LU2362541513.USD","BK4532","LU0109394709.USD","IE00B894F039.SGD","LU0234570918.USD","IE00B2B36J28.USD","BK4007","LU2462157665.USD","IBBQ","IE00BFTCPJ56.SGD","LU2417539215.USD","LU1093756168.USD","LU2237438978.USD","LU0061475181.USD","IE0002270589.USD","BK4585","PBE","BBH","IE0002141913.USD","LU2456880835.USD","VRTX","IE00BJT1NW94.SGD","IE00BZ9MQY76.HKD","LU0889565916.HKD","SG9999001176.SGD","LU0566484027.USD","CRNX","IE00B19Z9Z06.USD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650760159","title":"福泰制药百亿美元并购透露了什么讯号？","url":"https://stock-news.laohu8.com/highlight/detail?id=2650760159","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650760159?lang=zh_cn&edition=full","pubTime":"2026-07-11 22:55","pubTimestamp":1783781749,"startTime":"0","endTime":"0","summary":"01百亿美元级现金并购的底气福泰制药2025年全年营收120.01亿美元，同比增长9%，非GAAP净利润47.5亿美元，毛利率维持85%以上高位，账面现金及有价证券超过123亿美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1783569458583958068","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["SGXZ57979304.SGD","LU1093756168.USD","BK4567","IE00B894F039.SGD","BBH","BIB","SG9999001176.USD","IDNA","KCE","BK4532","LU0823416689.USD","IBBQ","IE00BFTCPJ56.SGD","LU0058720904.USD","LU1069344957.HKD","BK4139","LU1093756325.SGD","MYLD","IE00BJT1NW94.SGD","LU0109394709.USD","IE00B19Z9Z06.USD","IBB","LU1585245621.USD","LU1035775433.USD","BK4588","XMMO","LU0079474960.USD","IE00B4R5TH58.HKD","LU2236285917.USD","IE00B2B36J28.USD","IE00B19Z3581.USD","IE00B19Z9P08.USD","IE0002270589.USD","LU0320765992.SGD","SG9999001176.SGD","LU1778281490.HKD","LU0061475181.USD","IE00BJJMRZ35.SGD","LU2417539215.USD","VRTX","IE00BZ9MQY76.HKD","PBE","LU2324357040.USD","CALF","LU2462157665.USD","IE0002141913.USD","LU2362540622.SGD","IE0009355771.USD","LU0234570918.USD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649299398","title":"大摩解读福泰制药百亿收购Crinetics：补齐内分泌管线布局 两大核心药物打开增长空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2649299398","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649299398?lang=zh_cn&edition=full","pubTime":"2026-07-08 20:01","pubTimestamp":1783512080,"startTime":"0","endTime":"0","summary":"摩根士丹利发布研报，对福泰制药以100亿美元收购Crinetics的交易进行解读。此次收购将为福泰制药新增第五大业务支柱——内分泌药物，补齐公司管线布局。根据公告，每股85美元的收购价格较Crinetics周一的收盘价溢价了102%。值得注意的是，摩根士丹利担任福泰制药的财务顾问，协助该公司达成收购Crinetics的协议。","market":"us","thumbnail":"https://community-static.tradeup.com/news/7870ada20f73cf52a4a0efa576cd369c","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/7870ada20f73cf52a4a0efa576cd369c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1464871.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"大摩解读福泰制药(VRTX.US)百亿收购Crinetics：补齐内分泌管线布局 两大核心药物打开增长空间","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1791710400.SGD","LU0079474960.USD","LU0058720904.USD","LU0823416689.USD","LU1585245621.USD","BBH","IBBQ","BK4139","LU2362541273.HKD","PBE","LU0053666078.USD","KBWB","LU2487616109.SGD","LU1244550221.USD","LU2089284900.SGD","IE0002270589.USD","LU2456880835.USD","LU0267386448.USD","LU0432979614.USD","LU1720051017.SGD","LU0390134368.USD","IE00B19Z3581.USD","LU1732799900.SGD","IE00B19Z9P08.USD","BIB","LU2133065610.SGD","LU1674673691.USD","LU1720051108.HKD","IE00B894F039.SGD","LU2237438978.USD","LU0882574139.USD","LU0098860793.USD","BK4533","BK4588","LU2111349929.HKD","IBB","IAI","LU2236285917.USD","LU2362540622.SGD","SG9999001176.USD","BK4581","IDNA","LU0528227936.USD","IE0002141913.USD","IE00BZ9MQY76.HKD","VRTX","LU1363072403.SGD","LU0210528500.USD","IE0009355771.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649939579","title":"大摩解读福泰制药(VRTX.US)百亿收购Crinetics：补齐内分泌管线布局 两大核心药物打开增长空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2649939579","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649939579?lang=zh_cn&edition=full","pubTime":"2026-07-08 19:40","pubTimestamp":1783510856,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","LU0417517546.SGD","IE00BJJMRZ35.SGD","LU0795875169.SGD","LU1720051017.SGD","SG9999001176.SGD","LU0061475181.USD","LU2417539215.USD","SG9999001176.USD","LU2362540622.SGD","IBB","IBBQ","BK4127","LU2133065610.SGD","LU0882574139.USD","LU1548497426.USD","LU2487616109.SGD","BK4567","KBWB","IE00B19Z3B42.SGD","LU0823416689.USD","IDNA","LU1585245621.USD","IE00B19Z3581.USD","SG9999013999.USD","VRTX","LU1074936037.SGD","LU1674673428.USD","LU2362541273.HKD","LU0314104364.USD","LU1244550221.USD","IE00B19Z9Z06.USD","LU1430594728.SGD","LU2237438978.USD","IAI","BBH","LU0058720904.USD","LU0079474960.USD","LU0006306889.USD","LU1244550577.SGD","PBE","LU1668664300.SGD","LU2347655156.SGD","LU0795875086.SGD","LU2089283258.USD","LU2462157665.USD","LU0053666078.USD","LU2271345857.HKD","BIB","LU0267386448.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649969921","title":"RBC Capital上调福泰制药目标价至570美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2649969921","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649969921?lang=zh_cn&edition=full","pubTime":"2026-07-08 16:24","pubTimestamp":1783499090,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0058720904.USD","RY","IBB","IE00BFTCPJ56.SGD","LU0320765992.SGD","BIB","BK4207","IE00B894F039.SGD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU1093756168.USD","IE00B19Z9Z06.USD","LU2462157665.USD","LU0029864427.USD","BK4533","IE00B19Z9P08.USD","LU2456880835.USD","BK4532","LU2417539215.USD","LU1267930573.SGD","BK4585","LU0310800379.SGD","SG9999013999.USD","IDNA","IBBQ","LU2237438978.USD","BBH","LU0234570918.USD","VRTX","LU1778281490.HKD","LU1093756325.SGD","LU0823416689.USD","GSIB","LU2324357040.USD","LU2362540622.SGD","BK4139","PBE","LU0289739699.SGD","IE00B19Z3B42.SGD","BK4567","IE00B2B36J28.USD","LU0417517546.SGD","LU0708994859.HKD","SG9999001176.USD","LU0128525929.USD","UDN","UUP","IE00B4R5TH58.HKD","SGXZ57979304.SGD","LU1069344957.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111378876","title":"Vera Therapeutics股价飙升：肾病新药获FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1111378876","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111378876?lang=zh_cn&edition=full","pubTime":"2026-07-08 02:47","pubTimestamp":1783450047,"startTime":"0","endTime":"0","summary":"周二，Vera Therapeutics, Inc.的股价上涨约8%，此前美国食品药品监督管理局批准了其用于治疗IgA肾病的药物。这款名为Trutakna的药物通过阻断两种蛋白质来发挥作用，这两种蛋白质会促使免疫系统产生抗体，这些抗体在肾脏中积聚并造成损伤。这是美国首个获批同时靶向这两种蛋白质的药物，尽管已有其他几种药物治疗该疾病。福泰制药正在研发一种同样能阻断这两种蛋白质的类似药物，FDA预计将在今年晚些时候对此做出裁决。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0256863811.USD","LU2362541513.USD","IE00B19Z9Z06.USD","IDNA","PBE","LU0823416689.USD","LU0058720904.USD","LU1069344957.HKD","LU2237438978.USD","IE00B19Z3581.USD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","BIB","LU0320765992.SGD","LU2324357040.USD","LU2417539215.USD","LU0432979614.USD","SG9999013999.USD","LU2362541273.HKD","VRTX","LU0109394709.USD","IE00B2B36J28.USD","IE0009355771.USD","LU0289739699.SGD","BK4139","IE00B19Z9P08.USD","IE00BFTCPJ56.SGD","LU1674673691.USD","LU0417517546.SGD","LU0889565916.HKD","LU0079474960.USD","IBB","IE00B19Z3B42.SGD","BK4567","SG9999001176.USD","IE00BZ9MQY76.HKD","IBBQ","LU2236285917.USD","LU2362540622.SGD","IE0002141913.USD","LU1035775433.USD","LU0234570918.USD","LU0061475181.USD","IE0002270589.USD","IE00B4R5TH58.HKD","BK4588","LABU","LU1093756325.SGD","BK4585","LU1674673428.USD","LU1778281490.HKD","LU2462157665.USD","BK4539","LU1430594728.SGD","BBH","SGXZ57979304.SGD","IE00B894F039.SGD","BK4532","VERA","LU1093756168.USD","BK4533","LU1585245621.USD","SG9999001176.SGD","LU2456880835.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649708736","title":"100亿美元砸出史上最大收购：福泰制药(VRTX.US)溢价100%收购Crinetics(CRNX.US)，杀入内分泌赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2649708736","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649708736?lang=zh_cn&edition=full","pubTime":"2026-07-07 08:35","pubTimestamp":1783384535,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0109394709.USD","BBH","LU2324357040.USD","IE00B19Z3581.USD","BK4533","LU0061475181.USD","SG9999001176.SGD","LU2456880835.USD","VRTX","SG9999001176.USD","BK4588","IBB","LU0823416689.USD","LU1430594728.SGD","IE0002270589.USD","CRNX","LU1585245621.USD","LU1778281490.HKD","LU0079474960.USD","BK4139","IDNA","IE00B2B36J28.USD","LU0417517546.SGD","LU1035775433.USD","LU2417539215.USD","LU1674673691.USD","BK4007","LU0432979614.USD","LU0256863811.USD","IE00B4R5TH58.HKD","IBBQ","SGXZ57979304.SGD","BIB","LU0234570918.USD","LU0058720904.USD","LU1093756168.USD","LU2362541273.HKD","IE00BZ9MQY76.HKD","LU0889565916.HKD","IE00BJT1NW94.SGD","LU1093756325.SGD","LU2362540622.SGD","PBE","IE00BJJMRZ35.SGD","IE00B19Z9Z06.USD","LU0320765992.SGD","LU0289739699.SGD","IE00B19Z9P08.USD","BK4585","LU2237438978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159544198","title":"SEC文件披露：特定情况下交易终止，Crinetics Pharmaceuticals或需向福泰制药支付3.5047亿美元解约费","url":"https://stock-news.laohu8.com/highlight/detail?id=1159544198","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159544198?lang=zh_cn&edition=full","pubTime":"2026-07-07 05:22","pubTimestamp":1783372928,"startTime":"0","endTime":"0","summary":"根据一份提交给美国证券交易委员会的文件披露，Crinetics Pharmaceuticals Inc. 与福泰制药之间的交易若在特定情况下被终止，前者可能需要向后者支付高达3.5047亿美元的终止费用。该文件明确了触发这一巨额财务义务的具体情形。协议条款显示，这笔费用的支付并非自动生效，而是与特定的终止条件紧密挂钩。然而，这也同时意味着，一旦协议因规定情形破裂，Crinetics Pharmaceuticals将面临显著的财务支出。目前，市场正密切关注两家公司后续的动向以及该交易的具体进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","LU0889565916.HKD","IE00B894F039.SGD","IE00BFTCPJ56.SGD","IE00B19Z3581.USD","LU0058720904.USD","IE0002270589.USD","LU2362541513.USD","LU2417539215.USD","LU2362541273.HKD","SG9999001176.SGD","SG9999001176.USD","LU0432979614.USD","LU1430594728.SGD","BK4139","IE0002141913.USD","LU1035775433.USD","IE00B19Z3B42.SGD","LU1674673428.USD","LU2236285917.USD","LU2237438978.USD","LU2362540622.SGD","LU2456880835.USD","PBE","IE0009355771.USD","IE00B4R5TH58.HKD","BK4533","BBH","LU1093756168.USD","LU2324357040.USD","LU2462157665.USD","IE00BJT1NW94.SGD","LU1093756325.SGD","LU1585245621.USD","LU0320765992.SGD","BK4532","IE00B19Z9P08.USD","IE00BZ9MQY76.HKD","LU0109394709.USD","IBB","BK4007","SG9999013999.USD","LU1069344957.HKD","BK4588","LU0417517546.SGD","LU0823416689.USD","IDNA","BK4585","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU0079474960.USD","LU0256863811.USD","LU0234570918.USD","IBBQ","LU1674673691.USD","LU0061475181.USD","IE00B19Z9Z06.USD","SGXZ57979304.SGD","VRTX","CRNX","BK4567","BIB","LU1778281490.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649679149","title":"生物制药公司Crinetics盘后涨超100%福泰制药将以85美元/股收购公司。","url":"https://stock-news.laohu8.com/highlight/detail?id=2649679149","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649679149?lang=zh_cn&edition=full","pubTime":"2026-07-07 04:09","pubTimestamp":1783368555,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1093756325.SGD","IE00BJJMRZ35.SGD","BK4567","BK4585","LU1778281490.HKD","LU0823416689.USD","LU2462157665.USD","MRNX","LU2324357040.USD","IE00B19Z9Z06.USD","IE00BJT1NW94.SGD","IE0002141913.USD","UUP","PBE","LU0079474960.USD","MRNY","IE00B19Z3581.USD","LU1093756168.USD","LU1585245621.USD","BBP","LU1035775433.USD","LU2456880835.USD","VRTX","IE00BFTCPJ56.SGD","LU2236285917.USD","LU1674673691.USD","LU2362541273.HKD","BIB","LU1674673428.USD","LU2362540622.SGD","IE00B19Z9P08.USD","SG9999001176.USD","BK4588","BK4532","IDNA","IBBQ","LU2417539215.USD","LU2362541513.USD","UDN","BK4139","BK4533","BBH","IBB","SGXZ57979304.SGD","LU0061475181.USD","LU0289739699.SGD","SG9999013999.USD","LU0320765992.SGD","LU2237438978.USD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127833937","title":"Crinetics与福泰制药交易预计2029年提升后者非GAAP运营收入","url":"https://stock-news.laohu8.com/highlight/detail?id=1127833937","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127833937?lang=zh_cn&edition=full","pubTime":"2026-07-07 04:07","pubTimestamp":1783368452,"startTime":"0","endTime":"0","summary":"根据最新披露的财务预测，Crinetics Pharmaceuticals Inc. 与福泰制药达成的战略合作，预计将在2029年对福泰制药的非通用会计准则运营收入产生积极贡献。\n此次交易的结构设计旨在通过长期协同效应，增强福泰制药的盈利质量。分析指出，该合作不仅将拓展福泰制药在特定治疗领域的产品管线，还可能优化其整体运营效率。市场预期，随着合作项目进入成熟阶段，其对财务指标的正面影响将逐步显现。\n财务模型显示，此次合作带来的收入增长与成本协同效应，是推动非通用会计准则运营收入提升的关键因素。投资者正密切关注交易细节及后续整合进程，以评估其长期价值创造潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU0061475181.USD","LU1093756325.SGD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0417517546.SGD","IE00B19Z9Z06.USD","BBH","BK4588","LU0109394709.USD","BIB","LU0234570918.USD","LU1069344957.HKD","LU1430594728.SGD","BK4533","IE00B19Z3B42.SGD","LU0289739699.SGD","LU2362541273.HKD","VRTX","BK4585","LU0058720904.USD","SGXZ57979304.SGD","IE00B4R5TH58.HKD","LU2456880835.USD","IE0009355771.USD","LU0320765992.SGD","IE00BFTCPJ56.SGD","IE00B19Z3581.USD","LU2324357040.USD","LU0823416689.USD","LU2362540622.SGD","LU1674673691.USD","IE00BZ9MQY76.HKD","IE00B19Z9P08.USD","SG9999013999.USD","PBE","LU2462157665.USD","IBBQ","LU2362541513.USD","LU1674673428.USD","LU2237438978.USD","LU0079474960.USD","LU2417539215.USD","IBB","LU0256863811.USD","LU1778281490.HKD","LU2236285917.USD","SG9999001176.SGD","CRNX","LU1585245621.USD","LU0889565916.HKD","LU0432979614.USD","BK4139","IE0002270589.USD","SG9999001176.USD","IE00BJJMRZ35.SGD","IE0002141913.USD","IE00B894F039.SGD","BK4567","BK4007","LU1093756168.USD","IDNA","LU1035775433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179291339","title":"Crinetics Pharmaceuticals：融资获美国银行与摩根士丹利的45亿美元全额承诺过桥贷款支持","url":"https://stock-news.laohu8.com/highlight/detail?id=1179291339","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179291339?lang=zh_cn&edition=full","pubTime":"2026-07-07 04:06","pubTimestamp":1783368378,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals Inc. 的融资计划，已获得来自美国银行和摩根士丹利高级融资部门提供的总额高达45亿美元的全额承诺过桥贷款支持。这笔资金将为公司的战略推进提供坚实的财务后盾。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LU2462157665.USD","IE00B19Z3581.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU1430594728.SGD","LU1069344957.HKD","LU2237438978.USD","IDNA","LU2362540622.SGD","IE00B2B36J28.USD","LU0256863811.USD","BK4532","IE0002270589.USD","IE00BJJMRZ35.SGD","LU0320765992.SGD","IE0002141913.USD","LU0234570918.USD","SG9999001176.SGD","BK4533","LU0889565916.HKD","LU0823416689.USD","LU1585245621.USD","LU0432979614.USD","LU1674673428.USD","LU2456880835.USD","IE0009355771.USD","BIB","LU1093756325.SGD","LU2324357040.USD","BK4007","IE00B19Z3B42.SGD","LU0079474960.USD","LU0417517546.SGD","LU0061475181.USD","IE00B19Z9Z06.USD","LU0289739699.SGD","BK4588","LU2362541513.USD","LU1035775433.USD","BBH","LU0109394709.USD","LU1093756168.USD","IE00B894F039.SGD","SG9999013999.USD","LU1674673691.USD","PBE","SG9999001176.USD","IE00BZ9MQY76.HKD","LU1778281490.HKD","LU2417539215.USD","LU2236285917.USD","IE00B19Z9P08.USD","LU2362541273.HKD","BK4567","BK4585","SGXZ57979304.SGD","IBB","LU0058720904.USD","CRNX","VRTX","BK4139","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154393441","title":"福泰制药就囊性纤维化疗法Alyftrek与泛加拿大药品联盟签署意向书","url":"https://stock-news.laohu8.com/highlight/detail?id=1154393441","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154393441?lang=zh_cn&edition=full","pubTime":"2026-07-06 22:25","pubTimestamp":1783347947,"startTime":"0","endTime":"0","summary":"福泰制药与泛加拿大药品联盟就囊性纤维化治疗药物Alyftrek的潜在合作签署了意向书。此举标志着该药物在加拿大市场准入进程中的一个重要步骤，旨在为患者提供新的治疗选择。意向书的签署为后续正式协议的谈判奠定了基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","LU2417539215.USD","LU1778281490.HKD","BK4533","LU0417517546.SGD","LU0823416689.USD","LU1035775433.USD","LU2362541513.USD","IE00BJJMRZ35.SGD","IE00B19Z3B42.SGD","LU2362540622.SGD","PBE","IBB","LU2236285917.USD","LU1093756325.SGD","IE00B894F039.SGD","IE0002141913.USD","LU1430594728.SGD","LU1069344957.HKD","IE0002270589.USD","LU0289739699.SGD","IE00B2B36J28.USD","LU2462157665.USD","LU1585245621.USD","LU2456880835.USD","BIB","VRTX","IBBQ","LU1674673428.USD","LU0256863811.USD","BK4585","BK4567","SGXZ57979304.SGD","LU0079474960.USD","IE00B19Z3581.USD","BBH","LU0320765992.SGD","IDNA","LU1674673691.USD","SG9999013999.USD","IE00B4R5TH58.HKD","IE00BZ9MQY76.HKD","BK4139","LU2324357040.USD","LU1093756168.USD","IE00BJT1NW94.SGD","LU0061475181.USD","IE00B19Z9P08.USD","LU0109394709.USD","BK4532","LU0234570918.USD","IE00B19Z9Z06.USD","IE00BFTCPJ56.SGD","LU2237438978.USD","SG9999001176.USD","SG9999001176.SGD","LU2362541273.HKD","BK4588","LU0058720904.USD","LU0889565916.HKD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.proshares.com/funds/bib.html","stockEarnings":[{"period":"1week","weight":-0.022},{"period":"1month","weight":0.0604},{"period":"3month","weight":0.1835},{"period":"6month","weight":0.1418},{"period":"1year","weight":0.8601},{"period":"ytd","weight":0.2269}],"compareEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":0.0078},{"period":"3month","weight":0.035},{"period":"6month","weight":0.0721},{"period":"1year","weight":0.1647},{"period":"ytd","weight":0.0836}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.04688},{"month":2,"riseRate":0.5,"avgChangeRate":0.00449},{"month":3,"riseRate":0.4375,"avgChangeRate":-0.010634},{"month":4,"riseRate":0.5625,"avgChangeRate":0.01003},{"month":5,"riseRate":0.529412,"avgChangeRate":0.011921},{"month":6,"riseRate":0.705882,"avgChangeRate":0.044992},{"month":7,"riseRate":0.647059,"avgChangeRate":0.060184},{"month":8,"riseRate":0.5,"avgChangeRate":-0.001421},{"month":9,"riseRate":0.375,"avgChangeRate":-0.006751},{"month":10,"riseRate":0.4375,"avgChangeRate":-0.005173},{"month":11,"riseRate":0.8125,"avgChangeRate":0.085975},{"month":12,"riseRate":0.5,"avgChangeRate":-0.001322}],"exchange":"NASDAQ","name":"Ultra纳斯达克生物科","nameEN":"ProShares Ultra Nasdaq Biotechnology"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ultra纳斯达克生物科(BIB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ultra纳斯达克生物科(BIB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ultra纳斯达克生物科,BIB,Ultra纳斯达克生物科股票,Ultra纳斯达克生物科股票老虎,Ultra纳斯达克生物科股票老虎国际,Ultra纳斯达克生物科行情,Ultra纳斯达克生物科股票行情,Ultra纳斯达克生物科股价,Ultra纳斯达克生物科股市,Ultra纳斯达克生物科股票价格,Ultra纳斯达克生物科股票交易,Ultra纳斯达克生物科股票购买,Ultra纳斯达克生物科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ultra纳斯达克生物科(BIB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ultra纳斯达克生物科(BIB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}